Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells
about
sameAs
Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cellsProduction and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas.Paclitaxel resistance in untransformed human mammary epithelial cells is associated with an aneuploidy-prone phenotype.Lung cancer signature biomarkers: tissue specific semantic similarity based clustering of digital differential display (DDD) data.Clinical proteomics: present and future prospects.Class III beta-tubulin in human development and cancer.Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes.Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology.Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcoma cell lines is linked to tubulin-beta-III expressionSeptin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanesBlockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells.Roles of beta-tubulin residues Ala428 and Thr429 in microtubule formation in vivo.Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids.Microtubule-Associated Protein Tau, α-Tubulin and βIII-Tubulin Expression in Breast Cancer.Microtubule stabilising agents for cancer chemotherapy.Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cellsClass III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents?Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins.The Elephant in the Room: The Role of Microtubules in Cancer.Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.Measuring the persistence length of MCF7 cell microtubules in vitro.Quantitative analysis of the effect of tubulin isotype expression on sensitivity of cancer cell lines to a set of novel colchicine derivatives.Identification of Novel Key Molecules Involved in Spatial Memory Impairment in Triple Transgenic Mice of Alzheimer's Disease.Effects of Paclitaxel and Eribulin in Mouse Sciatic Nerve: A Microtubule-Based Rationale for the Differential Induction of Chemotherapy-Induced Peripheral Neuropathy.Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer.Structure-based approaches for the design of benzimidazole-2-carbamate derivatives as tubulin polymerization inhibitors.Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers.Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance
P2860
Q24806463-967A4517-AABF-4289-BF27-1D62AB5D1ECFQ24814838-7792F541-146A-45D7-B94E-B1255D5FE7F3Q30438626-4DB353E9-3307-4CCB-8FE2-97E0F5CE7713Q34466055-4D824248-7426-4776-8075-DCDEADBEBD38Q35053674-C26AEDA0-E88A-490D-A5EF-5117AB24910FQ35125146-D9D593A5-1F95-449F-820C-D17B375E3E98Q35172172-D8075C77-A7EF-49F4-B571-0524FA5B2FE1Q35634946-F5B300FE-265E-4647-A0D1-4C5652BE1743Q35830854-8E65764F-F1E8-4E55-BF27-240D8E17CB30Q36546567-FFBB5906-3DB4-4F4C-A393-27062DBAC03EQ36620293-AEAC94E3-A6C0-410E-BA66-BC25126310BAQ37334445-DE1FCE21-0F15-46CA-A6D4-942745C3F7F1Q37447324-954FDDF4-D933-4FCD-A3FA-CBC8C0DEF2F7Q37459115-85489229-8CD7-4CDD-928C-96623A8C216AQ37481355-6A43CE79-C6C6-474A-B3FA-3AD0305A07F1Q37511825-114F566F-B3BB-49A6-B4E6-A895B9D68F09Q38069185-0ADCC273-3B03-4D53-8665-80A917965139Q38305006-D200DBA0-5D22-4180-A94F-E51A5CE9EC90Q38672574-362DCB02-62AF-46CD-9FA5-83D8756E8D7CQ38695528-02BD3528-D9B3-41DB-9F59-554972A280F3Q39526966-ED1F5E2C-6417-49AA-A84E-DCDD3874B266Q39699060-9730E354-0CFB-438D-A3F2-9B1E62662047Q40686532-A9C23067-1EAA-48BD-9EC3-99BE76C2D100Q43909454-417FA226-809F-472D-BA4E-9642E0BC0086Q47218543-420D2932-1AA4-4B35-988C-B2AD662F3830Q48125891-5867F043-9DEC-4E9B-A290-8C4BF9C29105Q50847750-BD0FA113-94CB-47B2-9283-6F34A3FFD2B8Q58766772-7378F971-3F9F-423F-BD04-362B79E3CDE4
P2860
Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Increased levels of tyrosinate ...... tant MCF-7 breast cancer cells
@ast
Increased levels of tyrosinate ...... tant MCF-7 breast cancer cells
@en
Increased levels of tyrosinate ...... tant MCF-7 breast cancer cells
@nl
type
label
Increased levels of tyrosinate ...... tant MCF-7 breast cancer cells
@ast
Increased levels of tyrosinate ...... tant MCF-7 breast cancer cells
@en
Increased levels of tyrosinate ...... tant MCF-7 breast cancer cells
@nl
prefLabel
Increased levels of tyrosinate ...... tant MCF-7 breast cancer cells
@ast
Increased levels of tyrosinate ...... tant MCF-7 breast cancer cells
@en
Increased levels of tyrosinate ...... tant MCF-7 breast cancer cells
@nl
P1476
Increased levels of tyrosinate ...... tant MCF-7 breast cancer cells
@en
P2093
Asok Banerjee
P304
P356
10.1016/S0006-291X(02)00269-3
P407
P577
2002-04-26T00:00:00Z